|View printer-friendly version|
|April 04, 2002 4:12 p.m.|
|Teva Announces Agreement to Acquire Bayer France Generic Operations|
Jerusalem, Israel, April 4, 2002 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today, further to the release dated February 5, 2002, that it has reached an agreement with Bayer Pharma S.A. to acquire Bayer Classics S.A., its French generic pharmaceutical marketing company and related manufacturing facility for a purchase price of 97 million. Bayer Classics S.A. is the third largest supplier of generic pharmaceuticals to the French retail market. The transaction is expected to be completed during the second quarter of 2002.